Rewarming victims of hypothermia such as divers or immersion victims, parti
cipants in winter sports and military operations, and surgical patients on
cardiopulmonary bypass (CPB) may lead to vascular instability, multiorgan f
ailure, shock, and even death. While the causes of these rewarming symptoms
are unknown, they may be related to bacterial lipopolysaccharide (LPS) tra
nslocated from the intestines into the circulation due to splanchnic ischem
ia. We have determined LPS during the cooling (to 31.5 degrees-34.0 degrees
C) and rewarming phases of hypothermic surgery in 11 patients at the Stanf
ord University Medical Center. During rewarming, there was an LPS spike in
6/11, in one more patient there was an LPS spike during surgery but not dur
ing rewarming, and in 4/11 there was no rise in LPS, i.e., a temporary endo
toxemia occurred in 7/11 (63.6%) patients, usually at the commencement of r
ewarming. All four patients with no LPS spike received dexamethasone for at
least 7 days before surgery. We propose that hypothermia reduced splanchni
c blood flow (BF), causing ischemic damage to the gut wall and translocatio
n of LPS from the gut into the vascular space. Upon rewarming, splanchnic B
F is restored, the translocated LPS transits from the splanchnic to the sys
temic circulations as a bolus, and the gut wall is healed. No sequelae occu
rred in these patients because of their adequately functioning immune syste
ms. However, had they been immunocompromised, symptoms might have occurred.
Rewarming of accident victims probably also incurs a similar risk of endot
oxemia, and dexamethasone may have protected the gut wall. Further studies
are indicated.